{"nct_id":"NCT04323436","title":"Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations","status":"TERMINATED","status_verified_date":"2024-10","start_date":"2020-08-19","start_date_type":"ACTUAL","primary_completion_date":"2022-12-14","primary_completion_date_type":"ACTUAL","completion_date":"2023-01-26","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}